JANX
Janux Therapeutics Inc
NASDAQ: JANX · HEALTHCARE · BIOTECHNOLOGY
$14.37
+1.84% today
Updated 2026-04-30
Market cap
$882.06M
P/E ratio
—
P/S ratio
88.21x
EPS (TTM)
$-1.83
Dividend yield
—
52W range
$12 – $35
Volume
1.0M
Janux Therapeutics Inc (JANX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,577.00%
ROE
-11.50%
ROA
-9.55%
Debt/equity
0.02x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-4.24M | — | — | — |
| 2020 | $380000.00 | $-6.78M | -3.42% | -1,274.47% | -1,785.26% |
| 2021 | $3.64M | $-32.56M | 100.00% | -905.39% | -895.22% |
| 2022 | $8.61M | $-54.15M | 100.00% | -779.04% | -628.82% |
| 2023 | $8.08M | $-58.29M | 75.81% | -902.87% | -721.18% |
| 2024 | $10.59M | $-68.99M | 80.54% | -933.58% | -651.62% |
| 2025 | $10.00M | $-113.63M | 79.71% | -1,576.67% | -1,136.25% |